Recent progress on lanthanide scintillators for soft X-ray-triggered bioimaging and deep-tissue theranostics

27Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Lanthanide scintillators capable of converting the absorbed X-ray photon energy to ultraviolet (UV) or visible light, are emerged as promising nanoprobes for multifunctional diagnosis and deep-tissue antitumor therapy such as X-ray-excited fluorescence (XEF) imaging, X-ray-triggered photodynamic therapy (X-PDT), and soft X-ray-activated NO gas therapy. Such biomedical tools have the potential to overcome the major challenge of the depth barrier suffered by traditional optics. Recently, various lanthanide scintillators have been designed for diagnosis and therapy of deep-seated tumors. This minireview presents an overview of recent progress on the lanthanide-based scintillators and illustration of the potential challenges and future development.

Cite

CITATION STYLE

APA

Jiang, M., Deng, Z., Zeng, S., & Hao, J. (2021, August 1). Recent progress on lanthanide scintillators for soft X-ray-triggered bioimaging and deep-tissue theranostics. VIEW. John Wiley and Sons Inc. https://doi.org/10.1002/VIW.20200122

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free